Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis (Q28294866)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis |
scientific article |
Statements
Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis (English)
0 references
8 June 2006
0 references
25
0 references
3479-88
0 references
24
0 references